Moreover, 5,7-Dihydroxyflavone and TRAIL were well tolerated in mice and the combination of 5,7-Dihydroxyflavone and TRAIL reduced tumor burden in a hepatocarcinoma xenograft model. Here, TNFSF10 is linked to neoplasm.